Abstract
Objectives
The purpose of this study was to evaluate the effects of statin therapy on myocardial function as measured with echocardiography with tissue Doppler imaging (TDI) and strain imaging (SI) independent of its lipid‐lowering effect.
Background
Statin use is known to improve outcomes in the primary and secondary prevention of ischemic heart disease, but their use is also associated with myopathy, muscle weakness and in rare cases, rhabdomyolysis. We sought to evaluate whether TDI and SI is able to identify changes in myocardial function associated with statin use.
Methods
Myocardial function was evaluated in 28 patients via echocardiography with TDI and SI. We identified 12 patients (5 females) without overt cardiovascular disease (including hypertension, smoking, and diabetes) that were on statin therapy and compared their echocardiographic findings with 16 (12 females) age, sex, and cholesterol–profile‐matched controls. Tissue Doppler imaging parameters of diastolic (E′/A′ and E/E′) and systolic (S′) function were measured. Regional systolic function was obtained by SI in 4‐chamber, 2‐chamber, long axis, and average global views.
Results
There was no significant difference in myocardial function as measured by Doppler and minor differences as measured via TDI among the 2 groups. There was significantly better function noted with SI in the control group vs the statin group in the 4‐chamber (−19.05% ± 2.45% vs −16.47% ± 2.37% P = 0.009), 2‐chamber (−20.30% ± 2.66% vs −17.45% ± 4.29% P = 0.03), long axis (−17.63% ± 3.79% vs −13.83% ± 3.74% P = 0.01), and average global (−19.0% ± 2.07% vs −15.91% ± 2.81% P = 0.004) views.
Conclusion
Statin therapy is associated with decreased myocardial function as evaluated with SI. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (1.9 MB).
References
- 1. Jukema JW, Bruschke AVG, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91: 2528–2540. [DOI] [PubMed] [Google Scholar]
- 2. Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid‐lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001; 104: 387–392. [DOI] [PubMed] [Google Scholar]
- 3. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996; 348(9034): 1079–1082. [DOI] [PubMed] [Google Scholar]
- 4. Maycock CAA, Muhlestein JB, Horne BD, et al. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002; 40: 1777–1785. [DOI] [PubMed] [Google Scholar]
- 5.The Long‐Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339(19): 1349–1357. [DOI] [PubMed] [Google Scholar]
- 6. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin‐converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110: 1291–1295. [DOI] [PubMed] [Google Scholar]
- 7. Young‐Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92(12): 1379–1383. [DOI] [PubMed] [Google Scholar]
- 8. Reilly SD, Litovsky SH, Steinkampf MP, et al. Statins improve human coronary atherosclerotic plaque morphology. Tex Heart Inst J 2008; 35(2): 99–103. [PMC free article] [PubMed] [Google Scholar]
- 9. Chia S, Raffel OC, Takano M, et al. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study. Coron Artery Dis 2008; 19(4): 237–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Asbach P, Paetsch I, Stawowy P, et al. Statin‐associated focal myositis. Int J Cardiol 2007; 133(1): e33–e34. [DOI] [PubMed] [Google Scholar]
- 11. Needham M, Fabian V, Knezevic W, et al. Progressive myopathy with up‐regulation of MHC‐I associated with statin therapy. Neuromuscul Disord 2007; 17(2): 194–200. [DOI] [PubMed] [Google Scholar]
- 12. Pasternak RC, Smith SC, Bairey‐Merz CN, et al. ACC/AHA/ NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002; 40(3): 567–572. [DOI] [PubMed] [Google Scholar]
- 13. Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high‐risk patients. Arch Intern Med 2003; 163: 553–564. [DOI] [PubMed] [Google Scholar]
- 14. Antons KA, Williams CD, Baker SK, et al. Clinical perspectives of statin‐induced rhabdomyolysis. Am J Med 2006; 119: 400–409. [DOI] [PubMed] [Google Scholar]
- 15. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid‐lowering drugs. JAMA 2004; 292: 2585–2590. [DOI] [PubMed] [Google Scholar]
- 16. Staffa, JA , Chang, J , Green, L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002; 346: 539–540. [DOI] [PubMed] [Google Scholar]
- 17. Baker SK, Tarnopolsky MA. Statin myopathies: pathophysiologic and clinical perspectives. Clin Invest Med 2001; 24(5): 258–272. [PubMed] [Google Scholar]
- 18. Streb W, Duszańska A, Stabryła‐Deska J, et al. The comparison of contrast echocardiography and tissue Doppler imaging for evaluation of reperfused myocardium in patients with acute anterior myocardial infarction. Cardiol J 2008; 15(6): 548–554. [PubMed] [Google Scholar]
- 19. Marcucci C, Lauer R, Mahajan A. New echocardiographic techniques for evaluating left ventricular myocardial function. Semin Cardiothorac Vasc Anesth 2008; 12(4): 228–247. [DOI] [PubMed] [Google Scholar]
- 20. Marsan NA, Westenberg JJ, Tops LF, et al. Comparison between tissue Doppler imaging and velocity‐encoded magnetic resonance imaging for measurement of myocardial velocities, assessment of left ventricular dyssynchrony, and estimation of left ventricular filling pressures in patients with ischemic cardiomyopathy. Am J Cardiol 2008; 102(10): 1366–1372. [DOI] [PubMed] [Google Scholar]
- 21. St. Vrain J, Bilhorn K, Kurup S, et al. Strain imaging using speckle tracking in the cardiometabolic syndrome: method and utility. J CardioMetabolic Syn 2008; 3(4): 258–261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Lin LC, Wu CC, Yeh HI, et al. Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol‐enriched diet. Laboratory Investigation 2005; 85: 1224–1237. [DOI] [PubMed] [Google Scholar]
- 23. Abraham TP, Nishimura RA. Myocardial strain: can we finally measure contractility? J Am Coll Cardiol 2001; 37: 731. [DOI] [PubMed] [Google Scholar]
- 24. Mizuguchi Y, Oishi Y, Miyoshi H, et al. Impact of statin therapy on left ventricular function and carotid arterial stiffness in patients with hypercholesterolemia. Circ J 2008; 72(4): 538–544. [DOI] [PubMed] [Google Scholar]
- 25. Talini E, Di Bello V, Bianchi C, et al. Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin: a preliminary echocardiographic study. Atherosclerosis 2008; 197(1): 346–354. [DOI] [PubMed] [Google Scholar]
- 26. Bountioukos M, Rizzello V, Krenning BJ, et al. Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. Am J Cardiol 2003; 92(5): 613–616. [DOI] [PubMed] [Google Scholar]
- 27. Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001; 104(3): 317–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30(2): 474–480. [DOI] [PubMed] [Google Scholar]
- 29. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30(6): 1527–1533. [DOI] [PubMed] [Google Scholar]
- 30. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous doppler‐catheterization study. Circulation 2000; 102: 1788. [DOI] [PubMed] [Google Scholar]
- 31. Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol 2006; 210(1): 94–102. [DOI] [PubMed] [Google Scholar]
- 32. Shan K, Bick RJ, Poindexter BJ, et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta‐adrenergic receptor density in humans. J Am Coll Cardiol 2000; 36(3): 891–896. [DOI] [PubMed] [Google Scholar]
- 33. Wang M, Yip GWK, Wang A, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hyperten 2005; 23(1): 183–191. [DOI] [PubMed] [Google Scholar]
- 34. Mulukutla S, Marroquin O, Smith C, et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol 2004; 94(11): 1363–1366. [DOI] [PubMed] [Google Scholar]
- 35. Okazaki S, Yokoyama T, Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome. Circulation 2004; 110: 1061–1068. [DOI] [PubMed] [Google Scholar]